Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor

Abstract

Pediatric high-grade glioma is a rare tumor characterized by high mortality. The authors report the first case of a highgrade glioma associated with a GOPC(FIG)-ROS1 fusion in a pediatric patient. The patient underwent gross-total resection at the age of 4 years, followed by adjuvant high-dose chemotherapy and autologous hematopoietic stem cell rescue. At 30 months after transplantation, she remains disease free.